|
||
|
| Home |  |
Firm Description | |
Sectors Covered | |
Completed Transactions | |
Testimonials | |
Principals | |
M&A Report and Publications |
|
Contact Us | |
| Acquiring Party | Heraeus Vadnais, Inc., a maker of medical components within the Heraeus Group. |
|---|---|
| Transferring Party | Synovis Life Technologies, Inc. (Nasdaq:SYNO), a manufacturer of various surgical devices. |
| Sector | Medical Devices |
| Date | February 1, 2008 |
| Analysis Broadens Heraeus' customer base and product range, increasing its manufacturing capabilities and distribution network. The deal sharpens Synovis' focus on the soft tissue repair market. The interventional business, which reported sales of $30.2m, had been hit by recalls and product safety and insurance reimbursement concerns in the overall heart defibrillator and pacemaker business. Deal value - $29.5m. | |
The Walden Group is a leading healthcare investment banking firm specializing in mergers, acquisitions and strategic transactions. It also invests its own funds and, together with its expert operational partners, provides value-added services to help special companies reach critical milestones. This information is copyright © 2004-2007 The Walden Group, Inc. This information is provided as a service to the public but remains the intellectual property of The Walden Group, Inc and may not be reproduced in any manner without the written permission of The Walden Group, Inc. The information contained in the transactions table was derived from publicly available and other sources. Transaction analysis and other information are based, in part, upon public comments, Walden Group research and judgments, and reporting and research of others. The information is not intended to be relied upon as pronouncements by the transaction participants or for any other reason. | |